1-3 of 3
Gritta Janka-Schaub, MD
Close
Sort by
Journal Articles

Increased TNF/NGF Receptor Expression on BCP-ALL Blasts Carrying the Prognostically Favorable TEL-AML Rearrangement.

Anja Troeger, MD, Ludmila Glouchkova, PhD, Birgit Ackermann, PhD, Gabriele Escherich, MD, Roland Meisel, MD, Hans-Juergen Laws, MD, Helmut Hanenberg, MD, Silja Roettgers, PhD, Gritta Janka-Schaub, MD, Arndt Borkhardt, MD, Ulrich Goebel, MD, Dagmar Dilloo, MD
Journal: Blood
Blood (2007) 110 (11): 1431.
https://doi.org/10.1182/blood.V110.11.1431.1431
Published: 2007
Journal Articles

CALM-AF10 and HOX11L2 Abnormalities Define Poor Prognostic Subgroups in Pediatric T-Cell Acute Lymphoblastic Leukemia.

Martine van Grotel, MSc, Jules P.P. Meijerink, PhD, Max M. van Noesel, MD, PhD, H. Berna Beverloo, PhD, Anton W. Langerak, PhD, Tim S. Poulsen, PhD, Elisabeth R. van Wering, MD, PhD, E. Gritta Janka-Schaub, MD, PhD, Rob Pieters, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 3279.
https://doi.org/10.1182/blood.V106.11.3279.3279
Published: 2005
Journal Articles

Phase III Evaluation of Once-Daily, Oral Therapy with ICL670 (Exjade®) Versus Deferoxamine in Patients with β-Thalassemia and Transfusional Hemosiderosis.

Maria Cappellini, MD, Mohamed Bejaoui, MD, Silverio Perrotta, MD, Leyla Agaoglu, MD, Antonios Kattamis, MD, Patricia Giardina, MD, Gritta Janka-Schaub, MD, Herbert Opitz, PhD, Catherine Ressayre-Djaffer, PhD, Daniele Alberti, MD
Journal: Blood
Blood (2004) 104 (11): 3619.
https://doi.org/10.1182/blood.V104.11.3619.3619
Published: 2004